Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 19, 219-220 (2020)
doi: https://doi.org/10.1038/d41573-020-00012-4
Updates & Corrections
-
Correction 06 May 2020: The surname for Wayne C. Drevets was incorrect in the online pdf and print versions, and the online pdf has now been corrected.
References
Kanne S. M. et al. The Autism Impact Measure (AIM): initial development of a new tool for treatment outcome measurement. J. Autism Dev. Disord. 44, 168–179 (2014).
Ness S. L. et al. An Observational study with the Janssen Autism Knowledge Engine (JAKE®) in individuals with autism spectrum disorder. Front. Neurosci. 13, 111 (2019).
Berry, S. M. et al. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 313, 1619–1620 (2015).
Competing Interests
S.N., G.P., S.J., K.W., A.B., N.V.M., W.C.D. and H.M. are employees of Janssen Research & Development and hold company stocks/stock options. H.M. reports a patent, which is assigned to Icahn School of Medicine at Mount Sinai, Yale University, and NIH; no financial benefit was received from this patent. R.H. received reimbursement for consultation from Janssen Research & Development. B.L. has received research grant funding from the NIH, is a consultant to Janssen Research & Development, the Illinois Children’s Healthcare Foundation and is a board member of the Brain Research Foundation. D.M. is on the Scientific Advisory Board of Roche. G.D. is on the Scientific Advisory Boards of Janssen Research & Development, Akili, LabCorp, Tris Pharm and Roche, a consultant for Apple, Gerson Lehrman Group, and Axial Ventures, has received grant funding from Janssen Research and Development and is CEO of DASIO. She receives royalties from Guilford Press, Springer and Oxford University Press.